Institutional shares held 2,940
0 calls
0 puts
Total value of holdings $2K
$0 calls
$0 puts
Market Cap $8.18M
9,290,480 Shares Out.
Institutional ownership 0.03%
# of Institutions 1

Quarterly Institutional Activity in PTN

Shares Bought
Shares Sold
View Transactions

Latest Institutional Activity in PTN

Top Purchases

Q4 2023
Nbt Bank N A Shares Held: 80 ($70.4)
Q2 2022
Renaissance Technologies LLC Shares Held: 227K ($200K)
Q2 2022
Charles Schwab Investment Management Inc Shares Held: 129K ($114K)
Q2 2022
Geode Capital Management, LLC Shares Held: 1.75M ($1.54M)
Q2 2022
Hrt Financial LP Shares Held: 34.5K ($30.3K)

Top Sells

Q3 2022
Vanguard Group Inc Shares Held: 0 ($0)
Q3 2022
Black Rock Inc. Shares Held: 0 ($0)
Q2 2022
Millennium Management LLC Shares Held: 0 ($0)
Q2 2022
Goldman Sachs Group Inc Shares Held: 0 ($0)
Q2 2022
Citadel Advisors LLC Shares Held: 0 ($0)

About PTN

Palatin Technologies, Inc., a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company's lead product is Vyleesi, a melanocortin receptor (MCr) agonist for the treatment of premenopausal women with hypoactive sexual desire disorder. It is also developing oral PL8177, a selective MC1r agonist peptide that has completed Phase I clinical trial for the treatment of inflammatory bowel diseases. In addition, the company engages in the development of PL9643, a peptide melanocortin agonist active at multiple MCrs, including MC1r and MC5r for anti-inflammatory ocular indications, such as dry eye disease; and melanocortin peptides for diabetic retinopathy. Further, it is developing PL3994, a natriuretic peptide receptor (NPR)-A agonist and synthetic mimetic of the endogenous neuropeptide hormone atrial natriuretic peptide for cardiovascular indications; and PL5028, an NPR-A and NPR-binder to treat cardiovascular and fibrotic diseases, including reducing cardiac hypertrophy and fibrosis. The company was incorporated in 1986 and is based in Cranbury, New Jersey.


Insider Transactions at PTN

Insider Transaction List

View all
Date Insider Transaction Ownership Type Shares Traded Value / Price
View All Transactions

Last 12 Months Summary

Buy / Acquisition
292K Shares
From 9 Insiders
Grant, award, or other acquisition 286K shares
Open market or private purchase 6K shares
Sell / Disposition
57.3K Shares
From 4 Insiders
Open market or private sale 16.7K shares
Payment of exercise price or tax liability 40.6K shares

Track Institutional and Insider Activities on PTN

Follow PALATIN TECHNOLOGIES INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PTN shares.

Notify only if

Insider Trading

Get notified when an Palatin Technologies Inc insider buys or sells PTN shares.

Notify only if

News

Receive news related to PALATIN TECHNOLOGIES INC

Track Activities on PTN